| 1 | Health | 0.89% | |
| 2 | Study | 0.89% | |
| 3 | Cancer | 0.79% | |
| 4 | New | 0.64% | |
| 5 | Medicina | 0.57% | |
| 6 | COVID-19 | 0.5% | |
| 7 | Patients | 0.42% | |
| 8 | Disease | 0.38% | |
| 9 | Case | 0.34% | |
| 10 | COVID | 0.34% | |
| 11 | Risk | 0.34% | |
| 12 | Report | 0.32% | |
| 13 | Brain | 0.32% | |
| 14 | Salud | 0.3% | |
| 15 | Covid | 0.3% | |
| 16 | Hospital | 0.26% | |
| 17 | HIV | 0.25% | |
| 18 | May | 0.25% | |
| 19 | BMC | 0.24% | |
| 20 | Research | 0.23% | |
| 21 | Breast | 0.22% | |
| 22 | Vaccine | 0.22% | |
| 23 | Africa | 0.2% | |
| 24 | County | 0.2% | |
| 25 | Heart | 0.2% | |
| 26 | News | 0.19% | |
| 27 | Dengue | 0.19% | |
| 28 | Human | 0.17% | |
| 29 | Care | 0.17% | |
| 30 | Linked | 0.16% | |
| 31 | AI | 0.16% | |
| 32 | Syndrome | 0.16% | |
| 33 | Patient | 0.16% | |
| 34 | CDC | 0.16% | |
| 35 | Acute | 0.15% | |
| 36 | Israel | 0.15% | |
| 37 | Food | 0.14% | |
| 38 | Horoscopo | 0.14% | |
| 39 | China | 0.14% | |
| 40 | Rare | 0.14% | |
| 41 | World | 0.14% | |
| 42 | Treatment | 0.14% | |
| 43 | Children | 0.14% | |
| 44 | April | 0.14% | |
| 45 | Parkinsons | 0.14% | |
| 46 | Dieta | 0.14% | |
| 47 | Abril | 0.14% | |
| 48 | Diet | 0.13% | |
| 49 | Liver | 0.13% | |
| 50 | Public | 0.13% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine
MarketWatch
2024-04-18 23:23:00
Long COVID patients show immunological improvement two years after infection
Medical Xpress
2024-04-18 22:44:04
How to Use Naloxone Nasal Spray | Covid-19 | news-journal.com - Longview News
Journal
2024-04-18 21:29:54
How Scripts for Case Investigation and Contact Tracing Evolved During the COVID-19 Pandemic
JPHMP Direct
2024-04-18 21:10:31
How the US failed people in prisons during Covid: ‘Really important to learn from what happened’
Coronavirus | The Guardian
2024-04-18 19:00:28
A one-shot vaccine for COVID, flu and future viruses? Researchers say it's coming
Salon
2024-04-18 18:30:00
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial
Nature.com
2024-04-18 18:20:11
COVID-19 caused drop of 24.6M TEU in container market growth, BIMCO says
WorldCargo News
2024-04-18 17:15:23
Clinical features and risk factors in COVID-19 infections | IDR
Dove Medical Press
2024-04-18 14:32:01
Global disease burden study highlights COVID-19 impact and health inequities - News
Medical.Net
2024-04-18 11:35:00
Interstitial Lung Disease With Respiratory Failure After COVID-19 mRNA Vaccination
Cureus
2024-04-18 09:29:17
Arizona’s long-COVID cases top nation’s; Hispanics most likely to suffer
Daily Independent
2024-04-18 08:16:00
Medical Xpress
2024-04-18 07:30:01
COVID-19 caused 21% excess of respiratory infections last winter, analysis finds
University of Minnesota Twin Cities
2024-04-18 05:53:00
COVID-era bar restrictions violated owners’ rights, NC court rules
WSOC Charlotte
2024-04-18 05:46:07